NasdaqGM - Delayed Quote • USD
Castle Biosciences, Inc. (CSTL)
At close: April 26 at 4:00 PM EDT
After hours: April 26 at 4:20 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-5,626.00
-5,626.00
-41,655.00
-18,983.00
9,865.00
Investing Cash Flow
-16,183.00
-16,183.00
-166,545.00
-66,657.00
-4,748.00
Financing Cash Flow
-2,298.00
-2,298.00
1,515.00
5,421.00
305,890.00
End Cash Position
98,841.00
98,841.00
122,948.00
329,633.00
409,852.00
Income Tax Paid Supplemental Data
198.00
198.00
120.00
16.00
102.00
Interest Paid Supplemental Data
11.00
11.00
16.00
1.00
1,978.00
Capital Expenditure
-13,621.00
-13,621.00
-5,632.00
-3,483.00
-4,751.00
Issuance of Capital Stock
--
--
--
--
330,041.00
Repayment of Debt
-142.00
-142.00
-122.00
-8.00
-27,359.00
Free Cash Flow
-19,247.00
-19,247.00
-47,287.00
-22,466.00
5,114.00
12/31/2020 - 7/25/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BDSX Biodesix, Inc.
1.2350
-1.98%
CNTG Centogene N.V.
0.4889
+1.88%
SERA Sera Prognostics, Inc.
10.75
+3.97%
DMTK DermTech, Inc.
0.6031
+3.02%
OCX OncoCyte Corporation
2.4800
+1.64%
MYGN Myriad Genetics, Inc.
18.18
+1.11%
VCYT Veracyte, Inc.
19.31
-0.87%
GDR.L genedrive plc
5.38
-4.44%
VNRX VolitionRx Limited
0.9137
+2.65%
OLK Olink Holding AB (publ)
22.84
-1.00%